Ren YuFeng, Qiu Huizhi, Yuan Yujie, Ye Jinning, Tian Yunhong, Wen Bixiu, Zhang Weijun, Li Qun
Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P.R.China.
Department of Radiotherapy, cancer center of Guangzhou medical university, Guangzhou 510080, P.R.China.
J Cancer. 2017 Jun 3;8(9):1665-1672. doi: 10.7150/jca.19197. eCollection 2017.
To evaluate and improve the 7 edition International Union against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma. A retrospective review of the data from 905 patients with biopsy-proven non-disseminated nasopharyngeal carcinoma was performed. All the patients were examined by magnetic resonance imaging (MRI) and received radiotherapy. Satisfied distributions among the stages were observed in the 7 edition staging systems. LRFS only differed in classifications betweenT1 and T3, T1 and T4 (P=0.022 and P=0.016, respectively). Significant differences were observed between patients without and with masticator space involvement for OS, DMFS and PFS (p<0.05). No statistically significant differences in LRFS were observed among different groups with anatomical masticator space involvement. The DMFS between N2 and N3b, N3a and N3b were lack of significance (P=0.060 and P=0.59). The T category and N category were independent prognostic factors for the major endpoints in the Cox multivariate regression analysis (P<0.01). This study confirmed the prognostic value of the 7 edition UICC/AJCC staging system, the revisions of the 7 edition staging system are acceptable. However, our study also revealed limitations in the current staging system and suggested some potential modifications in future revision.
评估并改进第7版国际抗癌联盟/美国癌症联合委员会鼻咽癌分期系统。对905例经活检证实为非播散性鼻咽癌患者的数据进行回顾性分析。所有患者均接受磁共振成像(MRI)检查并接受放疗。在第7版分期系统中观察到各期之间分布满意。局部区域无复发生存期(LRFS)仅在T1与T3、T1与T4的分类上存在差异(分别为P = 0.022和P = 0.016)。对于总生存期(OS)、远处转移无病生存期(DMFS)和无进展生存期(PFS),有咀嚼肌间隙受累和无咀嚼肌间隙受累的患者之间存在显著差异(p<0.05)。在有解剖学咀嚼肌间隙受累的不同组之间,LRFS未观察到统计学显著差异。N2与N3b、N3a与N3b之间的DMFS无显著性差异(P = 0.060和P = 0.59)。在Cox多因素回归分析中,T类别和N类别是主要终点的独立预后因素(P<0.01)。本研究证实了第7版国际抗癌联盟/美国癌症联合委员会分期系统的预后价值,第7版分期系统的修订是可以接受的。然而,我们的研究也揭示了当前分期系统的局限性,并建议在未来修订中进行一些潜在的修改。